Frequently asked questions
What is the overall objective of GERoNiMO?
To better understand mechanisms underlying possible health effects of EMF;
To better characterise current and future population levels of EMF exposure in Europe;
To further the state of knowledge on EMF and health;
To improve health risk assessment of EMF; and
To underpin policy development and propose non-technological means to reduce EMF exposure.
What is the duration of the project?
GERoNiMO will run for a total five years, starting on the 1st January 2014.
How is GERoNiMO funded?
The project is mainly funded by the European Union (EU grant agreement 603794), in addition to various local and national funding sources.
What is novel about GERoNiMO?
Who is leading the project?
GERoNiMO is led by Barcelona Institut of Global Health (ISGlobal), based in Barcelona, Spain. The project is headed by principle investigator (PI) Professor Elisabeth Cardis, head of the ISGlobal Radiation Programme.
Which organisations are directly involved in this research?
The project consortium comprises a total of 19 institutions from 13 countries.
How can I find out more about GERoNiMO?
The GERoNiMO website (http://radiation.isglobal.org/index.php/geronimo-home) serves as the chief source of information about the project. Please contact us directly if you have further questions. If you wish to know more about those project activities being carried out by particular participating institutions or in specific countries, please contact the relevant project partner. Scientific articles originating from the project are listed under publications.